87 related articles for article (PubMed ID: 15880788)
1. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inhibition of coronary vasculogenesis is mediated, in part, by reduced responsiveness to endogenous angiogenic stimuli, including vascular endothelial growth factor A (VEGF-A).
Ivnitski-Steele ID; Friggens M; Chavez M; Walker MK
Birth Defects Res A Clin Mol Teratol; 2005 Jun; 73(6):440-6. PubMed ID: 15880788
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor rescues 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibition of coronary vasculogenesis.
Ivnitski-Steele ID; Walker MK
Birth Defects Res A Clin Mol Teratol; 2003 Jul; 67(7):496-503. PubMed ID: 14565620
[TBL] [Abstract][Full Text] [Related]
3. 2,3,7,8-tetrachlorodibenzo-p-dioxin reduces myocardial hypoxia and vascular endothelial growth factor expression during chick embryo development.
Ivnitski-Steele ID; Sanchez A; Walker MK
Birth Defects Res A Clin Mol Teratol; 2004 Feb; 70(2):51-8. PubMed ID: 14991911
[TBL] [Abstract][Full Text] [Related]
4. Early developmental 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure decreases chick embryo heart chronotropic response to isoproterenol but not to agents affecting signals downstream of the beta-adrenergic receptor.
Sommer RJ; Hume AJ; Ciak JM; Vannostrand JJ; Friggens M; Walker MK
Toxicol Sci; 2005 Feb; 83(2):363-71. PubMed ID: 15564318
[TBL] [Abstract][Full Text] [Related]
5. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inhibition of coronary development is preceded by a decrease in myocyte proliferation and an increase in cardiac apoptosis.
Ivnitski I; Elmaoued R; Walker MK
Teratology; 2001 Oct; 64(4):201-12. PubMed ID: 11598926
[TBL] [Abstract][Full Text] [Related]
6. Altering HIF-1α through 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure affects coronary vessel development.
Wikenheiser J; Karunamuni G; Sloter E; Walker MK; Roy D; Wilson DL; Watanabe M
Cardiovasc Toxicol; 2013 Jun; 13(2):161-7. PubMed ID: 23264063
[TBL] [Abstract][Full Text] [Related]
7. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cardiotoxicity induced by 2,3,7, 8-tetrachlorodibenzo-p-dioxin and related chemicals during early chick embryo development.
Walker MK; Catron TF
Toxicol Appl Pharmacol; 2000 Sep; 167(3):210-21. PubMed ID: 10986012
[TBL] [Abstract][Full Text] [Related]
9. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on murine heart development: alteration in fetal and postnatal cardiac growth, and postnatal cardiac chronotropy.
Thackaberry EA; Nunez BA; Ivnitski-Steele ID; Friggins M; Walker MK
Toxicol Sci; 2005 Nov; 88(1):242-9. PubMed ID: 16120746
[TBL] [Abstract][Full Text] [Related]
10. In ovo 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure in three avian species. 1. Effects on thyroid hormones and growth during the perinatal period.
Janz DM; Bellward GD
Toxicol Appl Pharmacol; 1996 Aug; 139(2):281-91. PubMed ID: 8806844
[TBL] [Abstract][Full Text] [Related]
11. Expression of the aryl hydrocarbon receptor (AhR) and AhR nuclear translocator during chick cardiogenesis is consistent with 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced heart defects.
Walker MK; Pollenz RS; Smith SM
Toxicol Appl Pharmacol; 1997 Apr; 143(2):407-19. PubMed ID: 9144457
[TBL] [Abstract][Full Text] [Related]
12. In ovo 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure in three avian species. 2. Effects on estrogen receptor and plasma sex steroid hormones during the perinatal period.
Janz DM; Bellward GD
Toxicol Appl Pharmacol; 1996 Aug; 139(2):292-300. PubMed ID: 8806845
[TBL] [Abstract][Full Text] [Related]
13. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) increases release of luteinizing hormone and follicle-stimulating hormone from the pituitary of immature female rats in vivo and in vitro.
Li X; Johnson DC; Rozman KK
Toxicol Appl Pharmacol; 1997 Feb; 142(2):264-9. PubMed ID: 9070348
[TBL] [Abstract][Full Text] [Related]
14. Dioxin perturbs, in a dose- and time-dependent fashion, steroid secretion, and induces apoptosis of human luteinized granulosa cells.
Heimler I; Rawlins RG; Owen H; Hutz RJ
Endocrinology; 1998 Oct; 139(10):4373-9. PubMed ID: 9751521
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cell migration and vessel formation by vascular endothelial growth factor and basic fibroblast growth factor in cultured embryonic heart.
Ratajska A; Torry RJ; Kitten GT; Kolker SJ; Tomanek RJ
Dev Dyn; 1995 Aug; 203(4):399-407. PubMed ID: 7496032
[TBL] [Abstract][Full Text] [Related]
16. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
[TBL] [Abstract][Full Text] [Related]
17. An imbalance between vascular endothelial growth factor and its soluble receptor in placental villous explants of intrauterine growth-restricted pregnancies.
Padavala S; Pope N; Baker P; Crocker I
J Soc Gynecol Investig; 2006 Jan; 13(1):40-7. PubMed ID: 16303323
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of coronary vasculogenesis/angiogenesis by hypoxia in cultured embryonic hearts.
Yue X; Tomanek RJ
Dev Dyn; 1999 Sep; 216(1):28-36. PubMed ID: 10474163
[TBL] [Abstract][Full Text] [Related]
19. Multiple growth factors regulate coronary embryonic vasculogenesis.
Tomanek RJ; Zheng W; Peters KG; Lin P; Holifield JS; Suvarna PR
Dev Dyn; 2001 Jul; 221(3):265-73. PubMed ID: 11458387
[TBL] [Abstract][Full Text] [Related]
20. In utero and lactational exposure of the male rat to 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs prostate development. 2. Effects on growth and cytodifferentiation.
Roman BL; Timms BG; Prins GS; Peterson RE
Toxicol Appl Pharmacol; 1998 Jun; 150(2):254-70. PubMed ID: 9653056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
